SEC ownership of Camp4 Therapeutics Corp

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001736730.

Comparable stake leader

5AM Ventures VI, L.P.

Disclosed value leader

Janus Henderson Group Ltd.

Comparable rows

50/50

Latest evidence

31 Mar 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
5AM Ventures VI, L.P.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
31 Mar 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001736730
Issuer location
Cambridge, MA

Ownership snapshot

Top shareholders of Camp4 Therapeutics Corp (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
5AM Ventures VI, L.P.
Disclosed value leader
Janus Henderson Group Ltd.
Comparable rows
50/50
Latest evidence
31 Mar 2026
13D/G 13F 3/4/5 Lead comparable stake: 12% 13D/G row: 5AM Ventures VI, L.P. Showing 1-8 of 50 holder rows.

Quick read

5AM Ventures VI, L.P. leads the comparable SEC ownership view at 12%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens 5AM Ventures VI, L.P.'s linked filing trail.
Comparable ownership Top 5
5AM Ventures VI, L.P. 12%
Janus Henderson Group Ltd. 12%
Coastlands Capital LP 10%
FMR LLC 9.5%
Polaris Management Co. VII, L.L.C. 8.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
5AM Ventures VI, L.P.
13D/G
Andrew J. Schwab
12%
$8,392,800
5,869,091 shares
$0 09 Sep 2025
Janus Henderson Group Ltd.
13D/G 13F
JANUS HENDERSON GROUP PLC · Company
12%
$37,908,892
6,307,636 shares
$0 31 Dec 2025
Coastlands Capital LP
13D/G
10%
$21,452,710
4,886,722 shares
$0 10 Sep 2025
FMR LLC
13D/G 13F
Company
9.5%
$28,968,451
4,918,243 shares
+$10,440,496 31 Dec 2025
Polaris Management Co. VII, L.L.C.
13D/G 3/4/5
Amir Nashat · 10%+ Owner
8.4%
$5,623,119
3,932,251 shares
$0 09 Sep 2025
Vivo Opportunity Fund Holdings, L.P.
13D/G
7.4%
$23,373,365
3,856,991 shares
+$1,788,900 31 Dec 2025
BALYASNY ASSET MANAGEMENT L.P.
13D/G 13F
Company
5.1%
$11,819,642
2,632,437 shares
$0 31 Mar 2026
Enavate Sciences GP, LLC
13D/G 3/4/5 13F
10%+ Owner · Company
4.8%
$10,955,517
2,495,562 shares
-$2,773,593 09 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$8,554,994.

Buys
$8,554,994
Insiders: 7
Sells
$0
Insiders: 0
Net
+$8,554,994
Shares: +5,588,885
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 5,588,885 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 5,588,885 0 $8,554,994 $0 +$8,554,994

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 23 reporting-owner rows connected to Camp4 Therapeutics Corp. Open a relationship link for the CIK-to-CIK filing trail.

Rows
23
Largest Forms 3/4/5 holder
Andrew J. Schwab
Net 12M change
+$8,554,993
Latest report
10 Jun 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Andrew J. Schwab Director, 10%+ Owner $8,686,917 Mixed 10 Jun 2026
5AM Partners VI, LLC 10%+ Owner $8,686,917 +$4,499,999 +107% Mixed 11 Sep 2025
Josh Mandel-Brehm Chief Executive Officer, Director $459,388 +$9,999 +2.2% Filing P/S 01 Apr 2026
Amir Nashat Director, 10%+ Owner $302,421 +$1,999,999 +661% Filing P/S 10 Jun 2026
Polaris Management Co. VII, L.L.C. 10%+ Owner $302,421 +$1,999,999 +661% Filing P/S 11 Sep 2025
Richard A. Young Director $280,516 +$24,999 +9.8% Filing P/S 10 Jun 2026
Kelly Gold Chief Financial Officer $111,997 +$9,999 +9.8% Filing P/S 01 Apr 2026
Yuri Maricich Chief Medical Officer $9,999 +$9,999 +100% Filing P/S 01 Apr 2026
Polaris Partners GP X, L.L.C. 10%+ Owner Mixed 15 Oct 2024
Northpond Ventures II GP, LLC 10%+ Owner Mixed 15 Oct 2024
Enavate Sciences GP, LLC 10%+ Owner Mixed 15 Oct 2024
Murray Stewart Director Mixed 10 Jun 2026
Douglas E. Williams Director Mixed 10 Jun 2026
Daniel Tardiff Chief Scientific Officer Mixed 01 Apr 2026
Steven H. Holtzman Director Mixed 10 Jun 2026
Michael F. MacLean Director Mixed 01 Apr 2026
James P. Boylan Director Mixed 25 Jun 2025
Ravi I. Thadhani Director Mixed 25 Jun 2025
Paula Ragan Director Mixed 25 Jun 2025
Michael J. Higgins Director Mixed 25 Jun 2025

Recent insider transactions for Camp4 Therapeutics Corp

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Douglas E. Williams CAMP Stock Option (Right to Buy) Award 28,000 28,000 10 Jun 2026 Direct
Richard A. Young CAMP Stock Option (Right to Buy) Award 28,000 28,000 10 Jun 2026 Direct
Andrew J. Schwab CAMP Stock Option (Right to Buy) Award 28,000 28,000 10 Jun 2026 Direct
Steven H. Holtzman CAMP Stock Option (Right to Buy) Award 28,000 28,000 10 Jun 2026 Direct
Murray Stewart CAMP Stock Option (Right to Buy) Award 28,000 28,000 10 Jun 2026 Direct
Amir Nashat CAMP Stock Option (Right to Buy) Award 28,000 28,000 10 Jun 2026 Direct
Daniel Tardiff CAMP Stock Option (Right to Buy) Award 170,000 170,000 01 Apr 2026 Direct
Yuri Maricich CAMP Stock Option (Right to Buy) Award 215,000 215,000 01 Apr 2026 Direct
Kelly Gold CAMP Stock Option (Right to Buy) Award 215,000 215,000 01 Apr 2026 Direct
Josh Mandel-Brehm CAMP Stock Option (Right to Buy) Award 580,000 580,000 01 Apr 2026 Direct
Michael F. MacLean CAMP Stock Option (Right to Buy) Award 56,000 56,000 01 Apr 2026 Direct
Daniel Tardiff CAMP Stock Option (Right to Buy) Award 145,500 145,500 11 Dec 2025 Direct
Yuri Maricich CAMP Stock Option (Right to Buy) Award 190,000 190,000 11 Dec 2025 Direct
Kelly Gold CAMP Stock Option (Right to Buy) Award 190,000 190,000 11 Dec 2025 Direct
Josh Mandel-Brehm CAMP Stock Option (Right to Buy) Award 425,000 425,000 11 Dec 2025 Direct
Andrew J. Schwab CAMP Common Stock Award 2,941,176 2,941,176 11 Sep 2025 By 5AM Ventures VII, L.P.
5AM Partners VI, LLC CAMP Common Stock Purchase $4,499,999 $1.53 2,941,176 2,941,176 11 Sep 2025 By 5AM Ventures VII, L.P.
Polaris Management Co. VII, L.L.C. CAMP Common Stock Purchase 86.1% $1,999,999 $1.53 1,307,189 2,825,500 11 Sep 2025 See footnote
Amir Nashat CAMP Common Stock Purchase 86.1% $1,999,999 $1.53 1,307,189 2,825,500 11 Sep 2025 See Footnote
Yuri Maricich CAMP Common Stock Purchase $9,999 $1.65 6,060 6,060 11 Sep 2025 Direct
Kelly Gold CAMP Common Stock Purchase 9.8% $9,999 $1.65 6,060 67,877 11 Sep 2025 Direct
Josh Mandel-Brehm CAMP Common Stock Purchase 2.23% $9,999 $1.65 6,060 278,417 11 Sep 2025 Direct
Richard A. Young CAMP Common Stock Purchase 9.78% $24,999 $1.65 15,151 170,010 11 Sep 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .